Nationwide Children’s Hospital-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Nationwide Children's Hospital - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014366
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nationwide Children’s Hospital (Nationwide Children’s) is a provider of pediatric health care and research services. The hospital offers pediatric services in the areas of gastroenterology, hematology and nutrition, heart care, left lip and palate, oncology ad bone marrow transplantation. It provides neonatal medicine, neurosciences, and plastic and reconstructive surgery, among others. Nationwide Children’s operates primary care centers, urgent care centers, behavioral health care centers, center for autism spectrum disorders and others throughout the US. The hospital provides education and training services to the medical professionals, doctors, and others. It operates through its facilities located in different parts of Ohio. Nationwide Children’s is headquartered in Columbus, Ohio, the US.

Nationwide Children’s Hospital – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nationwide Children’s Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Nationwide Children’s Hospital, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Nationwide Children’s Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Nationwide Children’s Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Nationwide Children’s Hospital, Medical Devices Deals, 2011 to YTD 2017 9
Nationwide Children’s Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Nationwide Children’s Hospital, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Sarepta Therapeutics Enters into Research Agreement with Nationwide Children’s Hospital 11
ProclaRx and Nationwide Children’s Hospital Enter into Partnership 12
Transformatix Technologies Forms Joint Venture With Nationwide Children’s Hospital 13
Licensing Agreements 14
Myonexus Therapeutics Enters into Licensing Agreement with Nationwide Children’s Hospital 14
Sarepta Therapeutics Enters into Licensing Agreement with Nationwide Children’s Hospital 15
AveXis Enters into Licensing Agreement with Nationwide Children’s Hospital for Development of Rett syndrome 16
AveXis Enters into Licensing Agreement with Nationwide Children’s Hospital for Development of Amyotrophic Lateral Sclerosis 17
Lattice Biotech Receives Rights to Anti-Infective Technology from University of Southern California, Ohio State University and Nationwide Children’s Hospital 18
Microbial Robotics Secures Oncolytic Herpes Simplex Virus (oHSV) from Nationwide Children’s Hospital 19
AveXis Amends Licensing Agreement with Nationwide Children’s Hospital 20
Milo Biotech Enters Licensing Agreement with Nationwide Children’s Hospital 21
Nationwide Children’s Hospital – Key Competitors 22
Nationwide Children’s Hospital – Key Employees 23
Nationwide Children’s Hospital – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 24
Recent Developments 25
Government and Public Interest 25
Jun 19, 2017: Combining Immunotherapies Effective Against Mouse Model of Cancer 25
Jan 06, 2017: Parent Project Muscular Dystrophy Awards Nationwide Children’s Hospital $2.2 Million Grant to Explore Gene Therapy in Duchenne Muscular Dystrophy 27
Jun 30, 2016: Researchers Develop Effective Strategy for Disrupting Bacterial Biofilms, Cause of Many Chronic and Recurrent Diseases 28
Mar 03, 2016: GenomeNext Tapped to Provide Genomic Sequence Analysis Supporting Ohio State University and Nationwide Children’s Hospital Co-sponsored Cancer Study 29
Product News 30
Apr 27, 2016: Groundbreaking Gene Therapy Clinical Trial Offers Glimmer Of Hope For Young Children With Rare Batten Disease 30
Feb 09, 2017: Two investigational antitumor agents work better together against MPNST and neuroblastoma 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Nationwide Children's Hospital, Pharmaceuticals & Healthcare, Key Facts 2
Nationwide Children's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Nationwide Children's Hospital, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Nationwide Children's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Nationwide Children's Hospital, Deals By Therapy Area, 2011 to YTD 2017 8
Nationwide Children's Hospital, Medical Devices Deals, 2011 to YTD 2017 9
Nationwide Children's Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Sarepta Therapeutics Enters into Research Agreement with Nationwide Children's Hospital 11
ProclaRx and Nationwide Children’s Hospital Enter into Partnership 12
Transformatix Technologies Forms Joint Venture With Nationwide Children's Hospital 13
Myonexus Therapeutics Enters into Licensing Agreement with Nationwide Children's Hospital 14
Sarepta Therapeutics Enters into Licensing Agreement with Nationwide Children's Hospital 15
AveXis Enters into Licensing Agreement with Nationwide Children’s Hospital for Development of Rett syndrome 16
AveXis Enters into Licensing Agreement with Nationwide Children’s Hospital for Development of Amyotrophic Lateral Sclerosis 17
Lattice Biotech Receives Rights to Anti-Infective Technology from University of Southern California, Ohio State University and Nationwide Children's Hospital 18
Microbial Robotics Secures Oncolytic Herpes Simplex Virus (oHSV) from Nationwide Children’s Hospital 19
AveXis Amends Licensing Agreement with Nationwide Children's Hospital 20
Milo Biotech Enters Licensing Agreement with Nationwide Children’s Hospital 21
Nationwide Children's Hospital, Key Competitors 22
Nationwide Children's Hospital, Key Employees 23
Nationwide Children's Hospital, Subsidiaries 24
Nationwide Children's Hospital, Joint Venture 24

★海外企業調査レポート[Nationwide Children’s Hospital-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Spotlight Innovation Inc (STLT):製薬・医療:M&Aディール及び事業提携情報
    Summary Spotlight Innovation Inc (Spotlight Innovation), formerly American Exploration Corp is a developer of proprietary technologies designed to treat rare, emerging and neglected diseases. The company’s product pipeline includes drug candidates for the treatment of cancer derived from specialized …
  • AeroCentury Corp.:戦略・SWOT・企業財務分析
    AeroCentury Corp. - Strategy, SWOT and Corporate Finance Report Summary AeroCentury Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Cantex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Cantex Pharmaceuticals Inc (Cantex), formerly ParinGenix Inc is a clinical stage biopharmaceutical company that focuses on the development of proprietary pharmaceuticals for the treatment of cancers and other disorders. The company's pipeline products include CX-01, a proprietary combination …
  • DxTerity Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary DxTerity Diagnostics Inc (DxTerity) is a medical device company that offers molecular diagnostic solutions. The company develops genomic tests for disease diagnosis and monitoring in its genomics laboratory. The company’s patient clinical research platform and dxcollect fingerstick collectio …
  • Ingram Entertainment Inc.:戦略・SWOT・企業財務分析
    Ingram Entertainment Inc. - Strategy, SWOT and Corporate Finance Report Summary Ingram Entertainment Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • FedEx Corp:企業の戦略・SWOT・財務分析
    FedEx Corp - Strategy, SWOT and Corporate Finance Report Summary FedEx Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Alkermes Plc (ALKS):企業の財務・戦略的SWOT分析
    Alkermes Plc (ALKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Steel Authority Of India Ltd:企業の戦略・SWOT・財務分析
    Steel Authority Of India Ltd - Strategy, SWOT and Corporate Finance Report Summary Steel Authority Of India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • North Pacific Bank,Ltd:企業の戦略・SWOT・財務情報
    North Pacific Bank,Ltd - Strategy, SWOT and Corporate Finance Report Summary North Pacific Bank,Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Albireo Pharma Inc (ALBO):製薬・医療:M&Aディール及び事業提携情報
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., focuses on the development and commercialization of innovative bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and diseases where inappropriate flow of bile causes severe med …
  • Power Assets Holdings Ltd (6):石油・ガス:M&Aディール及び事業提携情報
    Summary Power Assets Holdings Limited (Power Assets) a subsidiary of CK Infrastructure Holdings Limited, is an investment holding company. The company through its subsidiaries, joint ventures, and affiliates, invests in power and utility-related businesses. The company has interests in electricity g …
  • Yuhan Corp (000100):製薬・医療:M&Aディール及び事業提携情報
    Summary Yuhan Corp (Yuhan) researches, develops, manufactures and markets pharmaceutical products. The company offers API's and intermediates for antibiotic, antiviral, antifungal, anti-inflammatory, anti-diabetic, anti-HIV, anti-HCV, beta-lactase inhibitors, PEGlyated compounds and anti-histamines. …
  • Noni B Ltd (NBL):企業の財務・戦略的SWOT分析
    Noni B Ltd (NBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • China Animal Husbandry Industry Co Ltd (600195):企業の財務・戦略的SWOT分析
    China Animal Husbandry Industry Co Ltd (600195) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Omega Pharma NV:企業のM&A・事業提携・投資動向
    Omega Pharma NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Omega Pharma NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Momenta Pharmaceuticals Inc (MNTA):企業の財務・戦略的SWOT分析
    Momenta Pharmaceuticals Inc (MNTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Sfinks Polska S.A.:企業の戦略・SWOT・財務分析
    Sfinks Polska S.A. - Strategy, SWOT and Corporate Finance Report Summary Sfinks Polska S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • EZCORP Inc (EZPW):企業の財務・戦略的SWOT分析
    EZCORP Inc (EZPW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • BioScrip Inc (BIOS):医療機器:M&Aディール及び事業提携情報
    Summary BioScrip Inc (BioScrip), formerly MIM Corp is a healthcare service provider that provides infusion care services. The hospital offers a range of infusion services, PBM services and respiratory services. It provides infusion therapy services such as antimicrobial drugs, factor replacement the …
  • Teco Energy Inc:電力:M&Aディール及び事業提携情報
    Summary TECO Energy Inc (TECO), a subsidiary of Emera Inc., is an energy holding company for regulated electricity and gas utilities and other businesses. It generates, transmits, distributes, purchases and sells electricity; and purchases, distributes and sells natural gas through its subsidiaries. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆